Previous Article | Next Article ![]()
Journal of Virology, July 2005, p. 9296-9300, Vol. 79, No. 14
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.14.9296-9300.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
,
Michael A. D'silva,1,
,
Petric Kuballa,1,
Karin Butz,2
Felix Hoppe-Seyler,2 and
Martin Scheffner1*
Center for Biochemistry, Faculty of Medicine, and Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany,1 Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 242, 69120 Heidelberg, Germany2
Received 27 September 2004/ Accepted 31 March 2005
The ubiquitin-protein ligase E6-AP is utilized by the E6 oncoprotein of human papillomaviruses (HPVs) associated with cervical cancer to target the tumor suppressor p53 for degradation. Here, we report that downregulation of E6-AP expression by RNA interference results in both the accumulation of p53 and growth suppression of the HPV-positive cervical cancer cell lines HeLa and SiHa. In addition, HeLa cells, in which p53 expression was suppressed by RNA interference, are significantly less sensitive to the downregulation of E6-AP expression with respect to growth suppression than parental HeLa cells. These data indicate that the anti-growth-suppressive properties of E6-AP in HPV-positive cells depend on its ability to induce p53 degradation.
Present address: Philip Morris Research Laboratories, Fuggerstr. 3, 51149 Cologne, Germany.
A.H. and M.A.D. contributed equally to this work.
Present address: Dept. of Biology, University of Konstanz, 78457 Constance, Germany.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»